Happy to announce that Caplin Point Laboratories is listed on “Forbes Asia’s 200 Best Under a Billion companies” for the 5th time in the last 9 years. This remarkable achievement is a testament to our consistent growth and razor-sharp focus on benchmark cash flows and profitability.
Accomplishment of 5th year on the list stands unprecedented for an Indian Pharmaceutical company.
2014 | 2015 | 2016 | 2021 | 2022
** The annual Best Under A Billion list recognizes 200 top-performing publicly listed small and midsized companies from over 20,000 in the Asia-Pacific region with sales under US$1 billion.